Marvel Biosciences Corp (MRVL) — Defensive Interval Ratio
Marvel Biosciences Corp (MRVL) has a Defensive Interval Ratio of 28 days as of April 2023. Defensive assets of CA$69.36K (cash CA$-, short-term investments CA$-, receivables CA$69.36K) cover 28 days of daily cash needs of CA$2.47K/day. See how liquid is Marvel Biosciences Corp's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Marvel Biosciences Corp Defensive Interval Ratio (2020–2022)
This chart shows how Marvel Biosciences Corp's Defensive Interval Ratio has evolved across 3 annual periods from 2020 to 2022. As of April 2023, the ratio stands at 28 days, meaning defensive assets of CA$69.36K can fund 28 days of operations without new revenue. See how leveraged is Marvel Biosciences Corp's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Marvel Biosciences Corp (2020–2022)
The table below presents the year-by-year Defensive Interval Ratio for Marvel Biosciences Corp from 2020 to 2022, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MRVL market cap overview.
| Year | DIR (days) | Defensive Assets (CAD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2022 | 29 days | CA$56.44K | CA$1.97K/day | CA$- | CA$- | ▼ -163 days |
| 2021 | 192 days | CA$59.11K | CA$308.16/day | CA$- | CA$- | ▲ +118 days |
| 2020 | 74 days | CA$35.84K | CA$485.43/day | CA$- | CA$- | — |